{
  "description": "Test questions for RAG system evaluation based on indexed Cochrane reviews",
  "categories": {
    "treatment_effectiveness": [
      "What is the effectiveness of thrombopoietin receptor agonists for preventing chemotherapy-induced thrombocytopenia in patients with solid tumours?",
      "How effective are pathogen-reduced platelets compared to standard platelets for preventing bleeding?",
      "What are the benefits and risks of restrictive versus liberal red blood cell transfusion strategies in patients with haematological malignancies?",
      "Is a therapeutic-only platelet transfusion policy as effective as a prophylactic platelet transfusion policy for people with bone marrow failure disorders?",
      "What pharmacological interventions are effective for treating painful sickle cell vaso-occlusive crises in adults?",
      "What is the efficacy of hydroxyurea for treating sickle cell disease?",
      "How effective are inhaled bronchodilators for acute chest syndrome in sickle cell disease?",
      "What are the effects of polyclonal antithymocyte globulin compared to other treatments for aplastic anaemia?",
      "What is the effectiveness of immunotherapy for treating allergic rhinitis?",
      "How effective are probiotics for treating eczema in children?"
    ],
    "comparative_questions": [
      "What is the difference between restrictive and liberal red blood cell transfusion strategies for patients undergoing chemotherapy?",
      "How do pathogen-reduced platelets compare to standard platelets in terms of bleeding prevention and adverse events?",
      "What are the comparative effects of different platelet transfusion thresholds (5x10^9/L vs 10x10^9/L) for preventing bleeding?",
      "How do TPO-RAs (thrombopoietin receptor agonists) compare to placebo in preventing chemotherapy-induced thrombocytopenia?",
      "What are the differences between therapeutic-only and prophylactic platelet transfusion policies?",
      "How effective are NSAIDs versus opioids for managing sickle cell pain crises?",
      "What is the difference between bone marrow and peripheral blood stem cell transplantation outcomes?"
    ],
    "safety_and_adverse_effects": [
      "What are the adverse events associated with pathogen-reduced platelet transfusions?",
      "What safety concerns exist with thrombopoietin receptor agonists for chemotherapy-induced thrombocytopenia?",
      "Are there any serious adverse events when using restrictive versus liberal red blood cell transfusion strategies?",
      "What are the transfusion-related adverse events reported in platelet transfusion studies?",
      "What are the risks of platelet refractoriness with pathogen-reduced platelets?",
      "What adverse events are associated with pharmacological treatments for sickle cell vaso-occlusive crises?",
      "What are the safety profiles of different platelet transfusion strategies?"
    ],
    "statistical_and_outcomes": [
      "What are the mortality outcomes at 31-100 days for restrictive versus liberal red blood cell transfusion strategies?",
      "What is the incidence of clinically significant bleeding (WHO grade 2 or higher) with pathogen-reduced platelets?",
      "What are the platelet transfusion requirements when using therapeutic-only versus prophylactic policies?",
      "What is the quality of life impact of restrictive versus liberal transfusion strategies?",
      "What are the serious infection rates comparing restrictive and liberal red blood cell transfusion strategies?",
      "What are the corrected count increment (CCI) results for pathogen-reduced versus standard platelets?",
      "What is the time to first bleeding episode in platelet transfusion studies?",
      "What are the hospital readmission rates for different transfusion strategies?"
    ],
    "specific_conditions": [
      "What treatments are available for chemotherapy-induced thrombocytopenia?",
      "How should platelet transfusions be managed in patients with bone marrow failure disorders?",
      "What is the best approach for managing anaemia in patients with haematological malignancies?",
      "What interventions are effective for sickle cell disease pain crises?",
      "How should thrombocytopenia be managed in patients with solid tumours?",
      "What are the treatment options for aplastic anaemia?",
      "How is bleeding prevented in patients with chronic thrombocytopenia?"
    ],
    "population_specific": [
      "What are the effects of restrictive versus liberal transfusion strategies specifically in adults with acute leukaemia?",
      "How effective are platelet transfusions in paediatric patients with bone marrow failure?",
      "What are the transfusion requirements for elderly patients (over 65 years) with haematological malignancies?",
      "What is the effectiveness of treatments for sickle cell disease in adolescents and young adults?"
    ],
    "complex_multipart_queries": [
      "For patients with chemotherapy-induced thrombocytopenia, what are the most effective treatments, their associated adverse events, and how do they compare to standard care?",
      "Compare the effectiveness, safety, and quality of life outcomes of restrictive versus liberal red blood cell transfusion strategies for patients with haematological malignancies receiving intensive chemotherapy or stem cell transplantation.",
      "What is the evidence regarding platelet transfusion strategies for preventing bleeding in patients with bone marrow disorders, including both effectiveness and safety outcomes?",
      "Provide a comprehensive comparison of pathogen-reduced platelets versus standard platelets, including effects on bleeding, platelet recovery, transfusion requirements, and adverse events.",
      "What are the clinical outcomes, including mortality, bleeding, infections, and quality of life, when using different red blood cell transfusion thresholds in haematological malignancy patients?"
    ],
    "methodology_and_evidence_quality": [
      "What is the quality of evidence (GRADE) for the effectiveness of thrombopoietin receptor agonists in preventing chemotherapy-induced thrombocytopenia?",
      "What randomized controlled trials have been conducted on platelet transfusion strategies for bone marrow failure disorders?",
      "What are the limitations of the evidence for restrictive versus liberal red blood cell transfusion strategies?",
      "How many participants were included in studies comparing therapeutic-only versus prophylactic platelet transfusions?",
      "What is the risk of bias in studies evaluating pathogen-reduced platelets?"
    ],
    "pico_based_queries": [
      "For patients with solid tumours receiving chemotherapy (Population), what is the effectiveness of TPO-RAs (Intervention) compared to placebo (Comparison) for preventing thrombocytopenia (Outcome)?",
      "In patients with bone marrow failure disorders, how do therapeutic-only platelet transfusions compare to prophylactic transfusions for preventing bleeding episodes?",
      "For adults with sickle cell disease experiencing vaso-occlusive crises, what pharmacological interventions are most effective for pain relief?",
      "What are the outcomes for haematological malignancy patients when using restrictive versus liberal red blood cell transfusion thresholds?"
    ]
  },
  "metadata": {
    "total_questions": 57,
    "categories": 9,
    "notes": [
      "Questions are based on actual indexed data from Cochrane reviews",
      "Questions cover multiple medical topics: Blood disorders, Allergy/intolerance, Child health, etc.",
      "Questions test different query types: factual, comparative, statistical, complex",
      "All questions reference data that has been indexed in Weaviate"
    ]
  }
}

